Effect of formulation variables on design, in vitro evaluation of valsartan SNEDDS and estimation of its antioxidant effect in adrenaline-induced acute myocardial infarction in rats

被引:19
作者
Amin, Maha M. [1 ]
El Gazayerly, Omaima N. [1 ]
Abd El-Gawad, Nabaweya A. [2 ]
Abd El-Halim, Shady M. [2 ]
El-Awdan, Sally A. [3 ]
机构
[1] Cairo Univ, Pharmaceut & Ind Pharm Dept, Fac Pharm, Cairo, Egypt
[2] October 6 Univ, Fac Pharm, Pharmaceut & Ind Pharm Dept, Sixth Of October City, Egypt
[3] Natl Res Ctr, Dept Pharmacol, Cairo, Egypt
关键词
Angiotensin II antagonist; BCS class II; oxidative stress; ternary phase diagram; DRUG-DELIVERY SYSTEM; ENHANCED BIOAVAILABILITY; ORAL BIOAVAILABILITY; S-SNEDDS; OPTIMIZATION; SMEDDS; DISSOLUTION; IMPROVEMENT; INHIBITION;
D O I
10.3109/10837450.2015.1078354
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Valsartan is a specific angiotensin II antagonist used for the treatment of hypertension. It suffers from low aqueous solubility and high variability in its absorption after oral administration. The aim of this study was to improve the dissolution and thereby the bioavailability of Valsartan through the development of self nano-emulsifying drug delivery systems. Four ternary phase diagrams were constructed to identify the self-emulsification region of Capmul (R) MCM, Labrafil (R) M1944, Capryol (TM) 90 and Labrafac (R) PG together with Cremophore (R) RH 40 and Transcutol (TM) HP as oil, surfactant and co-surfactant, respectively. The effect of oil type, oil and surfactant concentration on droplet size and in vitro Valsartan dissolution were studied. The protective effect of the optimum formula F5 in adrenaline-induced oxidative stress in rats during myocardial infarction was determined. Formula F5 exhibited globule size of (13.95 nm) with 76.07% +/- 1.10 of Valsartan dissolved after five minutes compared to Disartan 80mg capsules (13.43%). Results revealed a significant reduction (p<0.05) in serum aspartate transaminase, creatine kinase myocardial band and malondialdehyde levels, while a significant increase (p<0.05) in serum glutathione in F5. Therefore, self nano-emulsifying drug delivery systems could be considered as a promising approach to improve the dissolution and thereby the bioavailability of Valsartan.
引用
收藏
页码:909 / 920
页数:12
相关论文
共 54 条
[11]   Nanoemulsion Components Screening and Selection: a Technical Note [J].
Azeem, Adnan ;
Rizwan, Mohammad ;
Ahmad, Farhan J. ;
Iqbal, Zeenat ;
Khar, Roop K. ;
Aqil, M. ;
Talegaonkar, Sushama .
AAPS PHARMSCITECH, 2009, 10 (01) :69-76
[12]   Improvement of the microbiological activity of topical ketoconazole using microemulsion systems [J].
Badawi, A. A. ;
Sakran, W. S. ;
Ramadan, M. A. ;
El-Mancy, S. M. S. .
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2012, 22 (06) :473-478
[13]   Design and development of cefdinir niosomes for oral delivery [J].
Bansal, Saurabh ;
Aggarwal, Geeta ;
Chandel, Pankaj ;
Harikumar, S. L. .
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2013, 5 (04) :318-325
[14]   Development, Optimization, and Characterization of Solid Self-Nanoemulsifying Drug Delivery Systems of Valsartan Using Porous Carriers [J].
Beg, Sarwar ;
Swain, Suryakanta ;
Singh, Harendra Pratap ;
Patra, Ch Niranjan ;
Rao, M. E. Bhanoji .
AAPS PHARMSCITECH, 2012, 13 (04) :1416-1427
[15]   Self-nanoemulsifying drug delivery systems: formulation insights, applications and advances [J].
Date, Abhijit A. ;
Desai, Neha ;
Dixit, Rahul ;
Nagarsenker, Mangal .
NANOMEDICINE, 2010, 5 (10) :1595-1616
[16]   Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan [J].
Dixit, Adhvait R. ;
Rajput, Sadhana J. ;
Patel, Samir G. .
AAPS PHARMSCITECH, 2010, 11 (01) :314-321
[17]  
El-Laithy Hanan M., 2008, Current Drug Delivery, V5, P170, DOI 10.2174/156720108784911695
[18]  
El-Mancy SMS, 2013, IMPROVEMENT PERFORMA, P226
[19]   Development of Solid SEDDS, V: Compaction and Drug Release Properties of Tablets Prepared by Adsorbing Lipid-Based Formulations onto NeusilinA® US2 [J].
Gumaste, Suhas G. ;
Dalrymple, Damon M. ;
Serajuddin, Abu T. M. .
PHARMACEUTICAL RESEARCH, 2013, 30 (12) :3186-3199
[20]  
Huda S, 2014, Bangladesh Med Res Counc Bull, V40, P25